Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 257

Results For "MIT"

4660 News Found

CAHO and Dozee join hands to discuss emerging role of AI in healthcare
Digitisation | March 30, 2023

CAHO and Dozee join hands to discuss emerging role of AI in healthcare

70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai


MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine
News | March 30, 2023

MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine

Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers


Granules India inaugurates packaging facility in Virginia
Supply Chain | March 30, 2023

Granules India inaugurates packaging facility in Virginia

The facility is over 79,000 square feet and is equipped with packaging lines


Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare
News | March 29, 2023

Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare

The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies


Zydus receives final approval from USFDA for Loperamide Hydrochloride Capsules
Drug Approval | March 29, 2023

Zydus receives final approval from USFDA for Loperamide Hydrochloride Capsules

Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of US $34.7 million in the United States


Integrated strategy needed to achieve 'TB Mukt Bharat'
Public Health | March 28, 2023

Integrated strategy needed to achieve 'TB Mukt Bharat'

Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis


Lupin receives tentative approval from USFDA for Valbenazine capsules
Drug Approval | March 28, 2023

Lupin receives tentative approval from USFDA for Valbenazine capsules

Valbenazine Capsules (RLD Ingrezza) had estimated annual sales of USD 1,235 million in the U.S. (IQVIA MAT December 2022).


Briefs: Morepen Laboratories and Zydus Lifesciences
Drug Approval | March 27, 2023

Briefs: Morepen Laboratories and Zydus Lifesciences

The company is addressing these observations


Lupin announces completion of pharmacovigilance inspection by USFDA
Drug Approval | March 27, 2023

Lupin announces completion of pharmacovigilance inspection by USFDA

The inspection included a comprehensive scrutiny of practices and procedures for reporting of adverse events of Lupin’s marketed products worldwide


Lupin announces successful completion of UK MHRA inspection of Pithampur facilities
Drug Approval | March 27, 2023

Lupin announces successful completion of UK MHRA inspection of Pithampur facilities

With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company